Targeted degradation and removal of amyloid beta plaques for the prevention and treatment of alzheimer’s diseases via engineered nano-scavenger exosomes
AssigneeSanta Clara University
InventorsBiao Lu, Renceh Flojo, Joy Ku
Life of this patent
Estimating the term…
Abstract
Exosome-Based Nano-Scavenger (EBNS) are provided to precisely target and remove Aβ plaques. Leveraging exosomes, natural cell-derived vesicles with tissue-penetrating capabilities, these exosomes were engineered to carry disease targeting antibodies and Aβ-degrading enzymes, clearing Aβ specifically, safely and effectively. EBNS can overcome existing treatment limitations and offer a promising avenue for Alzheimer's Disease therapy.
Claims7
A genetically engineered nano-scavenger exosome capable of binding and degrading a protein, the genetically engineered nano-scavenger exosome comprising an expression vector with a protein-specific binding moiety, wherein the protein-specific binding moiety is selected from the group consisting of a Single-Chain Fragment Variable (scFv), a Tissue Plasminogen Activator (tPA), Urokinase (UPA), an Insulin-Degrading eEnzyme (IDE), and a Neprilysin (NEP), wherein the protein-specific binding moiety is attached to an exosome, and wherein the protein-specific binding moiety is capable of binding and degrading the protein.
Dependencies are inferred from the claim text.